Investment Analysts’ Weekly Ratings Updates for DENTSPLY SIRONA (XRAY)

DENTSPLY SIRONA (NASDAQ: XRAY) recently received a number of ratings updates from brokerages and research firms:

• 5/12/2025 – DENTSPLY SIRONA had its price target raised by analysts at Barrington Research from $20.00 to $21.00. They now have an “outperform” rating on the stock.
• 5/9/2025 – DENTSPLY SIRONA was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating.
• 5/9/2025 – DENTSPLY SIRONA had its price target lowered by analysts at UBS Group AG from $27.00 to $25.00. They now have a “buy” rating on the stock.
• 4/30/2025 – DENTSPLY SIRONA had its price target lowered by analysts at Piper Sandler from $20.00 to $16.00. They now have a “neutral” rating on the stock.
• 4/15/2025 – DENTSPLY SIRONA was downgraded by analysts at Morgan Stanley from an “overweight” rating to an “equal weight” rating. They now have a $14.00 price target on the stock.

DENTSPLY SIRONA Price Performance

XRAY opened at $16.50 on Friday. The company has a fifty day moving average price of $14.39 and a two-hundred day moving average price of $17.43. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. DENTSPLY SIRONA Inc. has a 52 week low of $12.16 and a 52 week high of $28.47. The firm has a market capitalization of $3.29 billion, a PE ratio of -7.97, a P/E/G ratio of 1.80 and a beta of 0.92.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 EPS for the quarter, topping analysts’ consensus estimates of $0.29 by $0.14. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The firm had revenue of $879.00 million during the quarter, compared to analyst estimates of $854.75 million. During the same quarter in the previous year, the business earned $0.42 EPS. The business’s quarterly revenue was down 7.8% compared to the same quarter last year. As a group, analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 3.88%. The ex-dividend date of this dividend was Friday, March 28th. DENTSPLY SIRONA’s dividend payout ratio is presently -14.10%.

Insiders Place Their Bets

In other news, Director Gregory T. Lucier purchased 15,142 shares of the firm’s stock in a transaction dated Monday, March 3rd. The stock was bought at an average price of $16.51 per share, with a total value of $249,994.42. Following the acquisition, the director now directly owns 81,971 shares of the company’s stock, valued at approximately $1,353,341.21. This represents a 22.66% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 0.50% of the company’s stock.

Hedge Funds Weigh In On DENTSPLY SIRONA

Institutional investors and hedge funds have recently made changes to their positions in the company. Colonial Trust Co SC acquired a new position in shares of DENTSPLY SIRONA in the 4th quarter valued at $26,000. Riverview Trust Co acquired a new position in shares of DENTSPLY SIRONA in the 4th quarter valued at $26,000. MassMutual Private Wealth & Trust FSB grew its holdings in shares of DENTSPLY SIRONA by 648.4% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock valued at $27,000 after buying an additional 1,232 shares during the period. UMB Bank n.a. grew its holdings in shares of DENTSPLY SIRONA by 60.8% in the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock valued at $28,000 after buying an additional 564 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. acquired a new position in shares of DENTSPLY SIRONA in the 1st quarter valued at $25,000. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.